Catalyst Pharmaceuticals (NASDAQ:CPRX) reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:11 PM.
Here’s what investors need to know about the announcement.
Earnings
Catalyst Pharmaceuticals beat estimated earnings by 11.36%, reporting an EPS of $0.49 versus an estimate of $0.44.
Revenue was up $45.44 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 6.37% increase in the share price the next day.
Here’s a look at Catalyst Pharmaceuticals’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.42 | 0.32 | 0.21 | 0.19 |
| EPS Actual | 0.53 | 0.41 | 0.31 | 0.26 |
| Revenue Estimate | 92.73M | 81.62M | 58.09M | 53.62M |
| Revenue Actual | 99.58M | 85.37M | 60.76M | 57.24M |
To track all earnings releases for Catalyst Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
